Jeremy Cohen

Dr Jeremy Cohen MBBS, BSc, MRCP, FRCA,CICM Jeremy is a Senior Staff Specialist in Intensive Care Medicine at the Royal Brisbane Hospital. He trained in the UK, obtaining the MRCP and FRCA. He moved to Australia in 2001 and completed his Intensive Care training in 2003, winning the Don Harrison medal for best examination performance. Since qualification he has developed a research interest in adrenal function in critical illness, co authoring numerous research articles and book chapters on this topic, and has completed a PhD in this area. As part of this work he is a principal investigator on the multi-centre ADRENAL trial investigating the use of corticosteroid treatment in the management of septic shock. Jeremy has an interest in the use of simulation for teaching crisis management in Intensive Care, which he has studied at the internationally recognised Centre for Medical Simulation at Harvard. He is one of the founders and the current Director of the Intensive Care Crisis Event Management Course held at the Queensland Skills Development Centre, and of the Queensland Skills Training day. Jeremy is an examiner for the CICM General Fellowship Examination and a member of the General Examination Committee. He has been an instructor on numerous courses both locally and nationally, and is an Associate Editor for the Monitor current awareness journal for Intensivists. adrenal function in critical illness, corticosteroid treatment in septic shock, simulation for teaching crisis management in Intensive Care

[2026] Long-term survival in patients discharged alive from hospital following an intensive care unit admission with sepsis or septic shock in Australia and New Zealand: an observational cohort study [2026] Clinical assessment of the critically ill patient [2026] Adrenocortical insufficiency in critical illness [2026] Genetics in sepsis [2025] In vitro dexamethasone suppression of cytokine production assay and plasma total and free cortisol responses to ACTH in healthy volunteers [2025] A gene expression-based approach for the precision use of hydrocortisone in septic shock patients; a secondary analysis of the ADRENAL trial [2025] Fludrocortisone to treat patients with aneurysmal subarachnoid haemorrhage: Protocol for an international, phase 3, randomised, placebo-controlled, multicentre